Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML
2014 · Cancer · 171 citations
https://doi.org/10.1002/cncr.28974
D
David Rizzeri
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
David Rizzeri is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat